Related content

A phase II, open‐label evaluation of cysteamine tolerability in patients with Huntington's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 2, 2015-02 ,pp. : 288-289

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of telbivudine treatment: an open‐label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 9, 2015-09 ,pp. : 754-762

John Wiley & Sons Inc

Access to resources Recommend Favorite

OC05.04: Prenatal and postnatal neuroimaging for the prediction of outcome in fetuses with congenital cytomegalovirus infection

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. S1, 2016-09 ,pp. : 9-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial

By  

Oncology Research and Treatment, Vol. 34, Iss. 3, 2011-02 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

By Prasad Suyash   Harpin Val   Poole Lynne   Zeitlin Harry   Jamdar Saroj   Puvanendran Kanagasabai    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 379-394

Informa Healthcare

Access to resources Recommend Favorite